Marker Therapeutics Inc (MRKR)

[Marv79]

Looks like no Q3 2017 updates this week. We will need to wait for a revised baseline from the new CEO who is now accountable, hope it does not take too long and hope we are not too far behind schedule. We can not afford to go to market again for funding if cash runs low it will be a dilution disaster. Given the CEO change AZN buy-out off the table for now, who knows on MAYO and we are probably behind schedule in the clinic again. Wilson may have been suprised by this development which is not good, however, his alternative was the street so what he got was a very good deal (not us). Looks like a step in right direction but it is a "wait and see" on future stock purchases until we get better understanding on current company status and new CEO approach. Changes like this are usually viewed negative on the front end. It needs to go down and capitulate at some level then we will see where we are.

New CEO looks like he was smart enough to get a $1.1 Million dollars up front in salary and shares and close to $600,000 in severance due to change in control. Also he gets right ot buy in big over the next few years which could lead to further dilution Hope he is worth all this. Wilson should have been allowed to stay, however, can work until his contract is up. TPIV BOD's "smoothing" over Wilson exit to mitigate legal and regulatory exposure from TPIV not delivering in Q3 2017 as promised again. In summary, good move, very expensive move, but now a wait and see at best.